Litcius/Paper detail

Pathogenic mutations in UBQLN2 exhibit diverse aggregation propensity and neurotoxicity

Nathaniel Safren, Thuy P. Dao, Harihar Milaganur Mohan, Camellia Huang, Bryce Trotter, Carlos A. Castañeda, Henry L. Paulson, Sami J. Barmada, Lisa M. Sharkey

2024Scientific Reports19 citationsDOIOpen Access PDF

Abstract

The ubiquitin-adaptor protein UBQLN2 promotes degradation of several aggregate-prone proteins implicated in neurodegenerative diseases. Missense UBQLN2 mutations also cause X-linked amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Previously we demonstrated that the liquid-like properties of UBQLN2 molecular assemblies are altered by a specific pathogenic mutation, P506T, and that the propensity of UBQLN2 to aggregate correlated with neurotoxicity. Here, we systematically assess the effects of multiple, spatially distinct ALS/FTD-linked missense mutations on UBQLN2 aggregation propensity, neurotoxicity, phase separation, and autophagic flux. In contrast to what we observed for the P506T mutation, no other tested pathogenic mutant exhibited a clear correlation between aggregation propensity and neurotoxicity. These results emphasize the unique nature of pathogenic UBQLN2 mutations and argue against a generalizable link between aggregation propensity and neurodegeneration in UBQLN2-linked ALS/FTD.

Topics & Concepts

NeurotoxicityFrontotemporal dementiaNeurodegenerationMissense mutationAmyotrophic lateral sclerosisProtein aggregationMutationBiologyAutophagyUbiquitinMutantDementiaCell biologyGeneticsChemistryMedicinePathologyGeneToxicityApoptosisOrganic chemistryDiseaseAmyotrophic Lateral Sclerosis ResearchUbiquitin and proteasome pathwaysEndoplasmic Reticulum Stress and Disease